Great question, Jock.
If people traded on that sort of information it may well constitute insider trading. People come into information about companies that is not generally known all the time. Consider our trials, drug manufacturing partners, funding bodies, ethics committe, SAB, etc. who would all know of material information before it is announced. If any of these people traded on that information they may well be trading as insiders, which is unlawful.
The rules about insider trading apply to everyone and the duty to not trade on inside information rests with the individual.
Cheers
Densy
Ann: PharmAust Completes Share Purchase Plan, page-93
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $94.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $58.40K | 305.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 115000 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 86074 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |